Multiple Sclerosis

MS pulse Reels - How to Track MS | Acknowledge, Assess, Advocate

Discover a simple way to monitor MS using Acknowledge, Assess, and Advocate—helping you track changes and improve patient conversations.

MS Pulse Reels - MS Monitoring in Practice | Turning Tracking into Action

See how tracking MS symptoms over time can lead to better insights, stronger discussions, and more informed care decisions.

MS Pulse Reels

MS Pulse is a series of short, engaging reels covering different aspects of multiple sclerosis—from everyday challenges to practical insights. The series is designed to simplify complex topics and support better understanding, conversations, and care in MS.

MS pulse Reels - See the Bigger Picture: Why Tracking Matters

MS changes are often hard to notice day by day. This video shows how tracking over time helps you see the bigger picture and what’s really changing.

10 Mar 2026

Understanding PIRA in MS: An Overview with Dr. Barry Singer

Progression Independent of Relapse Activity (PIRA) represents the gradual, sustained worsening of disability that occurs even without relapses. In this video, Dr. Barry Singer explains how PIRA is defined, why it affects many patients across the MS spectrum, and how clinicians can better detect subtle changes that reflect true long-term progression.

10 Mar 2026

Understanding Kaplan–Meier Curves in MS: An Overview with Dr. Barry Singer

Kaplan–Meier curves play a key role in visualizing how clinical events—such as confirmed disability progression—evolve over time in MS studies. In this video, Dr. Barry Singer provides a clear, simplified walkthrough of how these curves are constructed, how patient data contributes to each step, and what curve separation really tells us about treatment impact. This resource offers an accessible foundation for anyone looking to better understand KM interpretation in MS research.

10 Mar 2026

Understanding 6‑Month CDP in MS: An Overview with Dr. Barry Singer

A simplified walkthrough of how 6‑month Confirmed Disability Progression (CDP) is measured in MS clinical trials. Dr. Barry Singer explains how EDSS changes are assessed, why sustained progression matters, and how this endpoint helps distinguish real, lasting disability worsening from temporary fluctuations.